These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 21268831)
41. GABAergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning procedure. Nobre MJ; Cabral A; Brandão ML Neuroscience; 2010 Dec; 171(4):1152-63. PubMed ID: 20937363 [TBL] [Abstract][Full Text] [Related]
42. [Expression and roles of corticotropin-releasing hormone, cortisol and dehydroepiandrosterone sulfate in preterm labour]. Ding YL; He AH Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):239-43. PubMed ID: 17631763 [TBL] [Abstract][Full Text] [Related]
43. Amygdaloid corticotropin-releasing factor is involved in the anxiolytic effect of acupuncture during ethanol withdrawal in rats. Zhao Z; Jin X; Wu Y; Yang X; Xu Y; Jiang JZ; Kim SC; Lee BH; Yang CH; Zhao R J Acupunct Meridian Stud; 2013 Oct; 6(5):234-40. PubMed ID: 24139460 [TBL] [Abstract][Full Text] [Related]
44. [Psychomotor responsiveness to corticoliberin in rats with active and passive adaptive strategy in water-immersion paradigm of depression]. Semenova OG; Semenova MG; Rakitskaia VV; Shaliapina VG Ross Fiziol Zh Im I M Sechenova; 2006 Aug; 92(8):1016-21. PubMed ID: 17217253 [TBL] [Abstract][Full Text] [Related]
45. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat. Harro J; Tõnissaar M; Eller M Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205 [TBL] [Abstract][Full Text] [Related]
46. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1). Al Chawaf A; Xu K; Tan L; Vaccarino FJ; Lovejoy DA; Rotzinger S Peptides; 2007 Jul; 28(7):1406-15. PubMed ID: 17644218 [TBL] [Abstract][Full Text] [Related]
48. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178 [TBL] [Abstract][Full Text] [Related]
49. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282 [TBL] [Abstract][Full Text] [Related]
50. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze. Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074 [TBL] [Abstract][Full Text] [Related]
51. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Cleare AJ; O'Keane V; Miell JP Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921 [TBL] [Abstract][Full Text] [Related]
52. In vitro effects of hypothalamic-pituitary-adrenal axis (HPA) hormones on Schistosoma mansoni. Morales-Montor J; Mohamed F; Ghaleb AM; Baig S; Hallal-Calleros C; Damian RT J Parasitol; 2001 Oct; 87(5):1132-9. PubMed ID: 11695379 [TBL] [Abstract][Full Text] [Related]
53. Adaptive behavior in active and passive rats after intranasal administration of corticotrophin-releasing hormone. Shalyapina VG; Rakitskaya VV; Petrova EI; Mironova VI Neurosci Behav Physiol; 2004 Feb; 34(2):193-7. PubMed ID: 15115327 [TBL] [Abstract][Full Text] [Related]
54. [The psychomodulating effect of sub-pyrogenic doses of interleukin-1beta during chronic administration to rats]. Sokolova ES; Liudyno VI; Simbirtsev AS; Klimenko VM Ross Fiziol Zh Im I M Sechenova; 2006 Mar; 92(3):299-307. PubMed ID: 16739639 [TBL] [Abstract][Full Text] [Related]
55. [Dehydroepiandrosterone sulfate effect at aldosterone level under cold exposure]. Obut TA; Saryg SK; Ovsiukova MV; Dement'eva TIu; Obut ET; Érdynieva TA Ross Fiziol Zh Im I M Sechenova; 2011 Feb; 97(2):214-7. PubMed ID: 21598681 [TBL] [Abstract][Full Text] [Related]
56. Effects of low doses of the novel dehydroepiandrosterone (DHEA) derivative BNN27 in rat models of anxiety. Fragkiadaki E; Katsanou L; Vartzoka F; Gravanis A; Pitsikas N Psychopharmacology (Berl); 2024 Feb; 241(2):341-350. PubMed ID: 37917180 [TBL] [Abstract][Full Text] [Related]
57. Response of dehydroepiandrosterone to corticotropin-releasing hormone stimulation in alcohol-dependent subjects. Adinoff B; Kiser JM; Martin PR; Linnoila M Biol Psychiatry; 1996 Dec; 40(12):1305-7. PubMed ID: 8959298 [No Abstract] [Full Text] [Related]